Table 2.
Laboratory blood test (liver and renal function and inflammatory markers) of COVID-19 patients at admission. Statistical significance was confirmed by Mann–Whitney U test.
| Variables | Survived [n = 32] | Deceased [n = 15] | Statistical significance |
|---|---|---|---|
| Urea [mmol/l], mean [SD] | 46.50 ± 13.84 | 10.55 ± 4.44 | p < 0.05∗ |
| Creatinine [mg/dl], mean [SD] | 90.08 ± 15.21 | 124.46 ± 57.22 | p < 0.05∗ |
| Uremic acid [mg/dl], mean [SD] | 271.92 ± 88.17 | 336.54 ± 158.26 | p < 0.05∗ |
| Glucose [mmol/l], mean [SD] | 7.21 ± 3.01 | 8.06 ± 4.53 | p > 0.05 |
| Direct bilirubin [μmol/l], mean [SD] | 2.24 ± 0.68 | 4.23 ± 2.87 | p < 0.05∗ |
| Total bilirubin [μmol/l], mean [SD] | 6.47 ± 3.33 | 8.83 ± 6.16 | p > 0.05 |
| AST [U/l], mean [SD] | 26.67 ± 13.67 | 53.00 ± 42.68 | p < 0.05∗ |
| ALT [U/l], mean [SD] | 31.50 ± 26.86 | 31.77 ± 25.01 | p > 0.05 |
| ALP [U/l], mean [SD] | 58.31 ± 13.20 | 61.38 ± 28.92 | p > 0.05 |
| LDH [U/l], mean [SD] | 351.92 ± 74.89 | 734.77 ± 278.73 | p < 0.05∗ |
| CK [U/l], mean [SD] | 125.21 ± 97.17 | 382.15 ± 365.28 | p < 0.05∗ |
| hsTnT [ng/ml], mean [SD] | 6.96 ± 3.52 | 59.92 ± 12.23 | p < 0.05∗ |
| gamaGT [U/l], mean [SD] | 104.08 ± 62.76 | 104.92 ± 22.12 | p > 0.05 |
| K [mmol/l], mean [SD] | 4.33 ± 0.40 | 4.25 ± 0.61 | p > 0.05 |
| Na [mmol/l], mean [SD] | 141.21 ± 1.47 | 140.23 ± 7.87 | p > 0.05 |
| Ca [mmol/l], mean [SD] | 2.25 ± 0.18 | 2.08 ± 0.14 | p > 0.05 |
| P [mmol/l], mean [SD] | 1.05 ± 0.21 | 1.09 ± 0.27 | p > 0.05 |
| Manganese [mmol/l], mean [SD] | 0.84 ± 0.11 | 0.89 ± 0.18 | p > 0.05 |
| CL [mmol/l], mean [SD] | 2.25 ± 0.18 | 100.52 ± 6.99 | p < 0.05∗ |
| Total proteins [g/l], mean [SD] | 67.75 ± 6.43 | 69.92 ± 6.59 | p > 0.05 |
| Albumin [g/l], mean [SD] | 42.50 ± 4.87 | 35.54 ± 4.77 | p > 0.05 |
| CRP [mg/l], mean [SD] | 23.58 ± 33.08 | 167.64 ± 19.93 | p < 0.05∗ |